MYELOPROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA

Clinical trials for MYELOPROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new MYELOPROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for MYELOPROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for tough blood cancers: testing aggressive drug cocktail

Disease control Recruiting now

This study is testing whether combining four different cancer drugs can help control aggressive forms of blood and bone marrow disorders. It's for adults with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia, including those whose disease has returned afte…

Matched conditions: MYELOPROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

MYELOPROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA

Get alerted when new MYELOPROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA trials appear

New hope for tough blood cancers: testing aggressive drug cocktail